Skip to content

FARMADA: what changed

BE 0757.726.683NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€46,176
2024 · €24,193+€21,983
Equity
-€77,613
2024 · -€123,789+€46,176
Cash
€2,595
2024 · €20+€2,575
Balance sheet total
€65,145
2024 · €66,173-€1,028

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets -€2,715

    down €2,715 (-25.3%), from €10,734 to €8,019

  • Cash +€2,575

    up €2,575 (+12,902%), from €20 to €2,595

    mainly Net result for the year (+€46,176) and Tax, wage and social debts (+€8,103)

  • Receivables within one year -€895

    down €895 (-1.6%), from €54,384 to €53,489

Equity and liabilities
  • Profit (loss) carried forward +€46,176

    up €46,176 (+26.6%), from -€173,789 to -€127,613

  • Current portion of long-term debt -€39,184

    down €39,184 (-70.8%), from €55,350 to €16,166

  • Trade debts -€11,971

    down €11,971 (-62.2%), from €19,247 to €7,276

  • Tax, wage and social debts +€8,103

    up €8,103 (+59.3%), from €13,665 to €21,767

    of which Remuneration and social security: +€5,867

  • Accrued charges and deferred income -€4,751

    down €4,751 (-11.8%), from €40,429 to €35,678

Income statement
  • Staff costs -€7,718

    down €7,718 (-8.4%), from €91,482 to €83,764

  • Gross operating margin +€7,653

    up €7,653 (+5.9%), from €129,128 to €136,781

  • Depreciation -€4,185

    down €4,185 (-60.7%), from €6,900 to €2,715

  • Financial charges -€2,259

    down €2,259 (-38.6%), from €5,858 to €3,598

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €24,193
Gross operating margin +€7,653
Staff costs +€7,718
Depreciation +€4,185
Other operating charges -€14
Other operating items +€182
Financial income -€0
Financial charges +€2,259
Result 2025 €46,176
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€41,159
Investment €0
Financing -€38,584
Cash 2024 €20
Net result for the year +€46,176
Depreciation +€2,715
Receivables within one year +€895
Deferred charges and accrued income -€6
Trade debts -€11,971
Tax, wage and social debts +€8,103
Accrued charges and deferred income -€4,751
Debts after one year +€600
Current portion of long-term debt -€39,184
Cash 2025 €2,595
brings cash intakes cash out
Every line side by side 38 lines
Line Code 2024 2025 Change %
Total assets 20/58 €66,173 €65,145 -€1,028 -1.6%
Fixed assets 21/28 €10,734 €8,019 -€2,715 -25.3%
Intangible fixed assets 21 €10,734 €8,019 -€2,715 -25.3%
Current assets 29/58 €55,439 €57,126 +€1,687 +3.0%
Amounts receivable within one year 40/41 €54,384 €53,489 -€895 -1.6%
Trade receivables 40 €54,384 €53,489 -€895 -1.6%
Cash at bank and in hand 54/58 €20 €2,595 +€2,575 +12,902%
Deferred charges and accrued income 490/1 €1,036 €1,042 +€6 +0.6%
Total equity and liabilities 10/49 €66,173 €65,145 -€1,028 -1.6%
Equity 10/15 -€123,789 -€77,613 +€46,176 +37.3%
Contributions 10/11 €50,000 €50,000 = 0.0%
Profit (loss) carried forward 14 -€173,789 -€127,613 +€46,176 +26.6%
Amounts payable 17/49 €189,962 €142,758 -€47,204 -24.8%
Amounts payable after more than one year 17 €61,200 €61,800 +€600 +1.0%
Financial debts 170/4 €61,200 €61,800 +€600 +1.0%
Amounts payable within one year 42/48 €88,333 €45,280 -€43,053 -48.7%
Current portion of amounts payable after more than one year 42 €55,350 €16,166 -€39,184 -70.8%
Trade debts 44 €19,247 €7,276 -€11,971 -62.2%
Suppliers 440/4 €19,247 €7,276 -€11,971 -62.2%
Taxes, remuneration and social security 45 €13,665 €21,767 +€8,103 +59.3%
Taxes 450/3 €3,588 €5,824 +€2,236 +62.3%
Remuneration and social security 454/9 €10,077 €15,944 +€5,867 +58.2%
Other amounts payable 47/48 €71 €71 = 0.0%
Accrued charges and deferred income 492/3 €40,429 €35,678 -€4,751 -11.8%
Non-recurring operating income 76A €3,792 €0 -€3,792 -100%
Remuneration, social security and pensions 62 €91,482 €83,764 -€7,718 -8.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €6,900 €2,715 -€4,185 -60.7%
Other operating charges 640/8 €513 €527 +€14 +2.8%
Non-recurring operating charges 66A €182 €0 -€182 -100%
Gross operating margin 9900 €129,128 €136,781 +€7,653 +5.9%
Operating profit (loss) 9901 €30,050 €49,774 +€19,724 +65.6%
Financial income 75/76B €0 €0 -€0 -100%
Recurring financial income 75 €0 €0 -€0 -100%
Financial charges 65/66B €5,858 €3,598 -€2,259 -38.6%
Recurring financial charges 65 €5,858 €3,598 -€2,259 -38.6%
Profit (loss) for the period before taxes 9903 €24,193 €46,176 +€21,983 +90.9%
Profit (loss) for the period 9904 €24,193 €46,176 +€21,983 +90.9%
Profit (loss) for the period to be appropriated 9905 €24,193 €46,176 +€21,983 +90.9%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.

Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.

Adjusted equity -€85,632
Capitalised earnings €60,329 to €84,460

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€77,613
Intangible fixed assets (21)
-€8,019
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€85,632

Capitalised earnings

net result for the year (9904)
2025
€46,176
2024
€24,193
excluding non-recurring income and charges
€20,583
2023
-€40,558
excluding non-recurring income and charges
-€41,419
2022
-€74,244
2021
-€83,180
Average result, excluding non-recurring income and charges
€8,446
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€60,329 / €70,383 / €84,460

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 9 November 2026 via checked.be.